Transforming mental healthcare from
art to science,
starting with PTSD.

We Target Biomarkers for a Precision Medicine Approach to Mental Health Disorders

Current mental healthcare tools are inadequate, leaving tens of millions of people suffering. PTSD healthcare is no exception, characterized by failures to understand and address its root cause.

Our approach is different. Pioneering research uncovered PTSD’s underlying mechanisms of action, and our comprehensive solution to both diagnosis and treatment centers on measurable, targetable brain biomarkers.

Latest News

  • Dr. Perusini featured in Project W "2023 Impact Report"

    January 2024

  • Columbia Women's Business Society (The Scope): Dr. Jennifer Perusini of Neurovation Labs

    February 28, 2023

  • The Women of New York Biotech: 2022 Year in Review

    December 30, 2022

Events

  • CEO Jennifer Perusini Presenting at St Andrews Defence Tech & STATIC

    April 8, 2024

    CEO Jennifer Perusini to present as an invited speaker at an event hosted by St Andrews Defence Tech and STATIC.

  • CEO Jennifer Perusini to be Keynote Panelist at Incubator Spring Showcase

    April 11, 2024

    CEO Jennifer Perusini to be Keynote Panelist at Barnard College Athena Center for Leadership Incubator Spring Showcase.

  • CEO Jennifer Perusini to present at Barnard College’s 4th Annual Startup Summit

    June 7, 2024

    Hosted by Barnard College's Athena Center for Leadership and Barnard Entrepreneurs Network.